Peter Jeffrey Gilbar

19PUBLICATIONS
6CO-AUTHORS
AutoimmunityMolecular imaging (incl. electron microscopy and neutron diffraction)Cancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 21, 2022
Case reports of acquired thrombotic thrombocytopenic purpura attributed to pembrolizumab.

Peter J Gilbar, Marcus Sr Dickey

|Jan 28, 2022
Acquired Hemophilia A following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab.

Aarya Murali, Philip Wong, Peter J Gilbar

|Jan 17, 2022
Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature.

Nicole R Pringle, Peter J Gilbar, Guranjan D Grewal

|Oct 14, 2021
Severe cisplatin-induced renal toxicity in a patient with xeroderma pigmentosum.

Peter J Gilbar, Khageshwor Pokharel

|Sep 17, 2021
Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer.

Hannah Van Belle, Sara A Hurvitz, Peter J Gilbar

|Jun 17, 2021
Preventing drug vial wastage and reducing expenditure associated with injectable cancer drugs: International oncology pharmacy survey.

Peter J Gilbar, Carole R Chambers, Felice Musicco

Pageof 4

Frequent Collaborators

1 joint publications

Shinya Suzuki

1 joint publications

Barry R Goldspiel

1 joint publications

Hannah Van Belle

1 joint publications

Sara A Hurvitz